SPECIAL NOTICE
A -- Epidemiologic Studies of Adverse Effects of Marketed Drugs
- Notice Date
- 5/8/2006
- Notice Type
- Special Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, MD, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- Reference-Number-RQN-1016957
- Response Due
- 6/21/2006
- Archive Date
- 6/21/2006
- Description
- The Food and Drug Administration anticipates awarding a sole source contract modification to Contract number HHSF223200510006C with Ingenix, Inc., Basking Ridge, New Jersey. Ingenix, Inc. is the incumbent contractor and is the only source capable of meeting the Government's requirements for this contract. The statutory authority for other than full and open competition is 41 U.S.C. 253 (c)(1) implemented by Federal Acquisition Regulation 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements. The basic contract, awarded on a full and open competition basis, was to gain access to data resources that can be used to conduct drug safety analyses to the benefit of the public's health; to respond expeditiously to urgent public safety concerns; to provide a mechanism for collaborative pharmacoepidemiological research designed to test hypotheses, particularly those arising from suspected adverse reactions reported to FDA, and to enable rapid access to U.S. population-based data sources to ensure public safety when necessary. The purpose of this contract modification is to perform the increasing number of drug safety studies needed within the contract?s statement of work. The original completion date for this contract, September 2010, will not change. THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. NO SOLICIATIONS WILL BE ISSUED. All questions regarding this posting must be in writing and can be sent via email to Fred.Ettehadieh@fda.gov. Only email responses will be accepted. Questions must be received by no later than 12:00pm (noon) EST, June 21, 2006. A modification to the contract will be issued on or after June 21, 2006.
- Place of Performance
- Address: Silver Spring, MD
- Zip Code: 20993
- Country: USA
- Zip Code: 20993
- Record
- SN01043684-W 20060510/060508220304 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |